Mammalian Stanniocalcin-1 (STC1) is a glycoprotein that has been implicated in various biological processes including angiogenesis. Aberrant STC1 expression has been reported in breast, ovarian and prostate cancers, but the significance of this is not well understood. Here, we report that oxidative stress caused a 40-fold increase in STC1 levels in mouse embryo fibroblasts (MEFs). STC1À/À MEFs were resistant to growth inhibition and cell death induced by H 2 O 2 or by 20% O 2 (which is hyperoxic for most mammalian cells); this is the first phenotype reported for STC1-null cells. STC1À/À cells had higher levels of activated MEK and ERK1/2 than their wild-type (WT) counterparts, and these levels were all reduced by stable expression of exogenous STC1 in STC1À/À cells. Furthermore, pharmacological inhibition by PD98059 or UO126 of MEK and therefore of ERK1/2 activation restored sensitivity of STC1À/À cells to oxidative stress. We also found that H 2 O 2 -induced STC1 expression in WT cells was abolished by inhibition of ERK1/2 activation. Thus, the ERK1/2 signaling pathway upregulates STC1 expression, which in turn downregulates the level of activated MEK and consequently ERK1/2 in a novel negative feedback loop. Therefore, STC1 expression downregulates prosurvival ERK1/2 signaling and reduces survival under conditions of oxidative stress.
Introduction
Stanniocalcin-1 (STC1) is a glycoprotein that has been highly conserved from fish to mammals (Chang et al., 2003) . In fish, it functions as a classic hormone that is secreted from endocrine glands, the Corpuscles of Stannius, in response to hypercalcemia and inhibits uptake of calcium through the gills and gut (Wagner et al., 1988; Sundell et al., 1992) . In mammals, STC1 is also a secreted glycoprotein (Jellinek et al., 2000) , but although recombinant human STC1 was found to be capable of inhibiting the uptake of calcium through the gills of goldfish (Olsen et al., 1996) , and of regulating the flux of calcium and phosphate across rat intestine (Madsen et al., 1998) and kidney (Wagner et al., 1997) , there is no evidence that it has a physiologic role in regulating serum calcium in mammals. Instead, mammalian STC1 is expressed in a variety of tissues (Chang et al., 1995 (Chang et al., , 1996 Olsen et al., 1996) and is thought to have an autocrine or paracrine role, but the possibility of an intracellular role also is suggested by evidence that STC1 localizes to mitochondria (McCudden et al., 2002; Westberg et al., 2007a) .
A number of studies, mostly correlative, of mammalian STC1 mRNA and protein expression have ascribed roles to STC1 ranging from angiogenesis (Kahn et al., 2000; Bell et al., 2001) , bone and muscle development (Jiang et al., 2000; Filvaroff et al., 2002; Varghese et al., 2002; Yoshiko et al., 2003) , inflammation (Iyer et al., 1999; Kanellis et al., 2003) , cellular metabolism (McCudden et al., 2002; Ellard et al., 2007) and cancer (Fujiwara et al., 2000; Ismail et al., 2000; Okabe et al., 2001; Welcsh et al., 2002) . Establishing the functional importance and relevance of these putative functions has proved difficult; moreover, STC1-null mice housed in standard laboratory conditions have no obvious phenotype (Chang et al., 2005) .
There have been a number of hints that STC1 may be involved in the cellular stress response. For example, STC1 expression is upregulated in response to hypoxia (Zhang et al., 2000; Lal et al., 2001) , and osmotic stress (Sheikh-Hamad et al., 2000) . In an in vitro model of wound healing, STC1 expression was found to be rapidly upregulated following provision of serum to serum-starved human fibroblasts (Iyer et al., 1999) . Furthermore, STC1 is regulated by the tumor suppressors BRCA1 (Welcsh et al., 2002) and p53 (Lai et al., 2007) , both of which play key roles in orchestrating DNA repair and growth arrest, or apoptosis, in response to various cellular stresses.
In the course of characterizing the properties of mouse embryo fibroblasts (MEFs) derived from wildtype (WT) and STC1À/À mice, we made the surprising observation that the STC1À/À MEFs had a survival advantage when grown at low cellular density in an atmosphere of 20% O 2 . We found a novel role for STC1 in the cellular response to oxidative stress, and showed that STC1 functions in a negative feedback loop with MEK and ERK 1/2. These results implicate STC1 in the regulation of a key pathway involved in the response to oxidative stress and governing cellular survival and proliferation.
Results
Primary STC1 þ / þ and STC1À/À MEFs, obtained from littermate embryos, were plated at 4 Â 10 4 cells/ 9.6 cm 2 well, cultured under standard culture conditions (that is, in a humidified atmosphere of 5% CO 2 and 20% O 2 at 37 1C), and were found to exhibit the same morphology (Figure 1a ), plating efficiency (Supplementary Figure S1 ) and proliferation rate (Figure 1b) . At clonogenic density, however, STC1À/À MEFs reproducibly formed more colonies than STC1 þ / þ MEFs (Figures 1c and d ), and this difference was markedly dependent on the plating density: the difference in colony formation was greater when cells were plated at 400 cells per dish than at 600 cells per dish (Figure 1d ).
Mouse cells experience oxidative stress due to the 20% O 2 tension of standard culture conditions (Parrinello et al., 2003) , and are sensitized to oxidative stress when plated at low density (Long et al., 2003) . We therefore tested the hypothesis that the enhanced clonogenic ability of STC1À/À MEFs may be due to resistance to oxidative stress. Low density growth and clonogenic growth at 20% O 2 was compared to growth at 3% O 2 , which more closely resembles physiological O 2 tensions within tissues (Vanderkooi et al., 1991) , and has been shown to result in less DNA damage than 20% O 2 (Parrinello et al., 2003; Di Micco et al., 2008) . MEFs Regulation of oxidative stress response by STC1 A Nguyen et al were plated at 1 Â 10 4 cells/9.6-cm 2 well (25% of the plating density employed for the growth curves carried out earlier). In 20% O 2 , but not in 3% O 2 , STC1À/À MEFs proliferated faster than their WT counterparts (Figure 2a) . Furthermore, MEFs proliferated at a faster rate in 3% O 2 compared to 20% O 2 , regardless of genotype (Figure 2a) . Addition of the antioxidant N-acetyl cysteine (Sigma-Aldrich, St Louis, MO, USA) to the culture medium eliminated the difference in growth rate between STC1 þ / þ and STC1À/À MEFs grown at low density in 20% O 2 (Figure 2b ). Regarding clonogenic growth, it was found that when MEFs were plated at 400 cells per dish, the difference in colony formation between STC1 þ / þ and STC1À/À MEFs observed at 20% O 2 was not seen at 3% O 2 (Figure 2c) . Collectively, the data indicate that the differences between STC1 þ / þ and STC1À/À MEFs result from a differential response to oxidative stress.
To examine whether STC1 expression is altered by oxidative stress, STC1 þ / þ MEFs were treated with a 45-min pulse of H 2 O 2 . Quantitative real-time reverse transcriptase PCR (RT-PCR) showed that H 2 O 2 induced STC1 mRNA expression up to 40-fold, with levels peaking at 9 h and dropping by 24 h to levels below the baseline of STC1 expression in untreated cells (Figure 3a) .
To further test the hypothesis that STC1À/À MEFs are more resistant to oxidative stress than their WT counterparts, primary STC1 þ / þ and STC1À/À MEFs were treated with a H 2 O 2 pulse. Cells were counted after 72 h and the cumulative population doublings (PDs) were calculated. It was found that STC1 þ / þ MEFs underwent a greater reduction in growth than STC1À/À MEFs (Figures 3b and c) .
Human STC1-expressing MEF clones (huSTC1) were generated from immortalized STC1À/À MEFs, and STC1 mRNA expression levels were measured by realtime RT-PCR. Although negligible levels of STC1 expression were detected in the parental STC1À/À MEFs and the Neomycin resistance gene (NEO)-expressing control, high levels were detected in huSTC1 clones A and G (100-and 10-fold higher than in the STC1 þ / þ MEF cell line, respectively). The huSTC1 clone D expressed STC1 mRNA at a tenth of the levels seen in immortalized STC1 þ / þ MEFs (Figure 3d) . In response to H 2 O 2 treatment, the immortalized STC1À/À MEFs exhibited higher cell yields than the immortalized STC1 þ / þ MEFs (Figure 3e) , consistent with the response of primary STC1 þ / þ and STC1À/À MEFs. STC1 expression rescued the growth phenotype: the huSTC1-expressing clones had a greater reduction in growth than the parental STC1À/À MEFs or the NEO controls in response to H 2 O 2 treatment (Figures 3e and  f) . As the immortalized MEFs exhibited the same differential response to H 2 O 2 as the primary STC1 þ / þ and STC1À/À MEFs, and are a more abundant resource, most subsequent experiments utilized immortalized MEFs. Immortalized STC1 þ / þ MEFs grew more slowly than STC1À/À MEFs (Supplementary Figure S2) . Furthermore, huSTC1 clones A, D and G exhibited significantly slower growth than their NEO counterpart or their STC1À/À parental cells, indicating that the expression of STC1 reduced the growth rate of immortalized MEFs. 
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To establish whether there were differences in the levels of intracellular reactive oxygen species (ROS) between STC1 þ / þ and STC1À/À MEFs following H 2 O 2 treatment that might account for the differential survival response, cells were loaded with a cell permeable dye, carboxy-H 2 DCFDA (DCF), which fluoresces upon oxidation by ROS. DCF fluorescence was increased 24 h after H 2 O 2 treatment, but there were no differences between STC1 þ / þ and STC1À/À MEFs ( Figure 3g ).
To determine whether the upregulation of STC1 by other stimuli reduces cell survival, we induced hypoxia with cobalt chloride because hypoxia had previously been found to induce STC1 expression in cancer cells (Zhang et al., 2000; Yeung et al., 2005) . As in the cancer cells, STC1 mRNA expression was induced in STC1 þ / þ MEFs by hypoxia (Supplementary Figure S3A) , and we found that STC1À/À MEFs exhibited greater survival than STC1 þ / þ MEFs (Supplementary Figure S3B) .
In a model of neuronal cell hypoxia, the cytokine IL-6 was found to upregulate STC1 expression, and this was dependent upon p44/p42 MAPK (also known as ERK1/2) signaling (Westberg et al., 2007b) . The ERK family of proteins play central roles in regulating the survival of cells in response to oxidative stress (Wang et al., 1998) , so we examined whether altered ERK1/2 signaling might account for the resistance of STC1À/À MEFs to oxidative stress. Western blot analysis for phosphorylated ERK1/2 revealed that STC1À/À MEFs had higher levels of activated ERK1/2 than STC1 þ / þ MEFs (Figure 4a ), but total ERK1/2 protein levels in STC1 þ / þ and STC1À/À MEFs were similar (Figure 4a ). Therefore, STC1 inhibits the activation of ERK1/2, but does not affect total ERK1/2 protein levels. Notably, higher levels of activated ERK1/2 were present also in the primary STC1À/À MEFs, compared with primary STC1 þ / þ MEFs (Supplementary Figure S4) .
To further analyse the mechanism of enhanced ERK1/2 activation in STC1À/À MEFs, we examined the Raf-1/MEK/ERK signaling cascade. Western blots showed higher levels of phosphorylated MEK in STC1À/À MEFs compared with STC1 þ / þ MEFs, but there was no difference in the level of total MEK protein or activated Raf-1 between the two cell types Figure 4 Effects of ERK inhibition on MEF response to H 2 O 2 and STC1 expression. Lysates were collected from (a) H 2 O 2 -treated MEFs 6 h post-treatment and (b) from STC1À/À MEFs stably expressing huSTC1 or NEO The lysates were electrophoresed and immuno-blotted for components of the Raf/MEK/ERK1/2 signaling cascade as listed above. Representative blots from three representative experiments are presented. (c) MEFs were pre-treated with 50 mM PD98059, and then with 40 mM H 2 O 2 . After 72 h in culture, the cell yields were determined, mean±s.d., n ¼ 3. (d) MEFs were treated with 40 mM H 2 O 2 and then cultured in 10 mM UO126. After 48 h in culture, the cell yields were determined, mean±s.d., n ¼ 3. (e) RNA was isolated from PD98059 pre-treated cells 7 h posttreatment, and STC1 mRNA expression levels were assessed using real-time RT-PCR, mean ± s.d., n ¼ 3. Data shown in each panel are representative of three independent experiments. huSTC1, human STC1; MEFs, mouse embryo fibroblasts; RT-PCR, reverse transcriptase PCR; STC1, Stanniocalcin-1.
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A Nguyen et al (Figure 4a ), suggesting that STC1 acts downstream of Raf-1, inhibiting ERK1/2 signaling at the level of MEK activation. Consistent with this, STC1À/À MEFs with stable expression of human STC1 exhibited lower levels of phosphorylated ERK1/2 and phosphorylated MEK compared with the NEO controls (Figure 4b ), but did not differ in the levels of phosphorylated Raf-1 (Figure 4b ). The data suggest that STC1 inhibits ERK1/2 signaling and that the higher levels of activated ERK1/2 in STC1À/À MEFs were directly related to their resistance to oxidative stress.
To test this, ERK 1/2 signaling was disrupted by PD98059, a specific pharmacological inhibitor of MEK. Pretreatment of cells with PD98059 suppressed H 2 O 2 -induced ERK1/2 phosphorylation (data not shown) and reduced survival of STC1À/À MEFs to a level comparable to that of STC1 þ / þ MEFs after H 2 O 2 treatment (Figure 4c ). Intriguingly, PD98059 pretreatment had little effect on the survival of H 2 O 2 -treated STC1 þ / þ MEFs. Similar results were obtained in experiments in which ERK1/2 activation was inhibited using UO126, another specific pharmacological inhibitor of MEK. STC1 þ / þ MEF cell yields remained the same, regardless of whether MEK was inhibited or not, but in contrast STC1À/À MEF cell yields were significantly reduced when MEK was inhibited by UO126 (Figure 4d) . Collectively, the data indicate that ERK1/ 2 signaling is required for the resistance of STC1À/À MEFs to oxidative stress.
We next examined the effects of ERK1/2 inhibition on STC1 expression in the context of oxidative stress. We found that in PD98059 pretreated cells, H 2 O 2 -induced STC1 mRNA expression was suppressed (Figure 4e ), suggesting that ERK1/2 activity is required for STC1 expression induced by oxidative stress.
To determine whether STC1 regulates ERK1/2 signaling in conditions other than oxidative stress, STC1 þ / þ and STC1À/À MEFs were treated with recombinant human basic fibroblast growth factor (bFGF), which has been shown to stimulate ERK1/2 (Besser et al., 1995) . Western blot analysis confirmed the ability of bFGF to activate ERK1/2 (Figure 5a ), and also revealed higher levels of phosphorylated MEK and phosphorylated ERK1/2 in STC1À/À MEFs compared with STC1 þ / þ MEFs (Figure 5a ). The activation of ERK1/2 by bFGF was accompanied by an increase in cell yield in both sets of cells, but to a greater extent in STC1À/À MEFs than STC1 þ / þ MEFs (Figure 5b) . Cells can undergo apoptosis or growth arrest in response to cellular stress, and dysfunction in either of these fundamental processes can compromise genomic integrity. An efficient and intact stress response is therefore crucial to maintenance of genetic stability and consequently for tumor suppression also. To analyse the nature of the resistance to oxidative stress exhibited by STC1À/À MEFs, we used fluorescenceactivated cell sorting (FACS) to examine the cell cycle distribution of the cells following oxidative insult. Consistent with earlier results (Arrington et al., 2000) , we found that H 2 O 2 caused an arrest in G 2 /M phase. The proportion of cells in G 2 /M was 35% in the H 2 O 2 -treated set compared to 25% in the untreated set. There was no difference between STC1 þ / þ and STC1À/À MEFs in this respect (data not shown). Thus there were no indications of a failure to undergo growth arrest in response to H 2 O 2 that could account for the resistance of STC1À/À MEFs. The sub-G 1 peak in the STC1 þ / þ sample was slightly larger than that of the STC1À/À sample, which suggested that the STC1À/À MEFs were more resistant to H 2 O 2 -induced apoptosis. Caspase 3/7 activity was assessed using a luminescent cleavage assay and indeed the levels of these apoptosis effector molecules in STC1À/À MEFs were lower than in STC1 þ / þ MEFs (Figure 6a ). Intriguingly, STC1À/À MEFs exhibited lower levels of caspase 3/7 activity regardless of whether the cells had been exposed to H 2 O 2 or not. When MEFs were exposed to PD98059 before H 2 O 2 treatment, the differences in caspase 3/7 activity between STC1 þ / þ and STC1À/À MEFs were no longer apparent (Figure 6b ), indicating that ERK1/2 activity is required for the resistance of STC1À/À MEFs to apoptosis.
Discussion
We report here the first phenotype directly attributable to complete loss of STC1 function. We found that STC1À/À MEFs have enhanced survival compared with WT cells when grown at low cell density in an atmosphere of 20% O 2 , but that they had no survival advantage in 3% O 2 . Under physiological conditions, most cells are exposed to oxygen tensions that are an (a) Lysates were collected from MEFs after 3 h exposure to 80 ng/ ml bFGF, electrophoresed and immunoblotted for phosphorylated MEK and phosphorylated ERK1/2. A representative blot from four independent experiments is shown. (b) MEFs were treated with 80 ng/ml bFGF for 48 h cells, harvested and then counted using a particle counter. Cell yields are represented as a percentage of the corresponding untreated culture, mean ± s.d., n ¼ 3. bFGF, basic fibroblast growth factor; FGF, fibroblast growth factor; MEFs, mouse embryo fibroblasts; STC1, Stanniocalcin-1.
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A Nguyen et al order of magnitude lower than those in air (Vanderkooi et al., 1991) , so 20% O 2 represents hyperoxia, and 3% O 2 is much closer to normoxia, and this result therefore indicated that STC1À/À MEFs are resistant to oxidative stress. This conclusion was confirmed by showing that the growth difference in 20% O 2 could be abolished by an antioxidant. We confirmed this further by showing that exposure to H 2 O 2 induced STC1 expression 40-fold in WT cells, and reduced their survival much more than did similar treatment of STC1À/À cells. The survival advantage of STC1À/À cells was negated by expression of exogenous STC1. These data indicate that STC1 has a negative effect on prosurvival signaling pathways and/or has a positive effect on cell death signaling (Figure 7 ). The levels of intracellular ROS in STC1 þ / þ and STC1À/À MEFs were similar before and after H 2 O 2 treatment, indicating that the antisurvival effect of STC1 is not mediated through alteration of cellular antioxidant levels or ROS metabolism.
On the basis of the finding that the upregulation of STC1 expression by the cytokine IL-6 was mediated by ERK1/2 (Westberg et al., 2007b) , we found that ERK1/ 2 also mediated the oxidative stress-induced upregulation of STC1 levels. We also discovered, however, that STC1 negatively regulated MEK, the kinase upstream of ERK1/2, ultimately impacting upon the activation of ERK1/2. Our results suggest that STC1 functions in a negative feedback loop to regulate MEK and ERK1/2. The higher levels of activated MEK and ERK1/2 in STC1À/À MEFs were associated with resistance to oxidative stress, in agreement with the observation that ERK1/2 has a mitogenic or prosurvival function (Wang et al., 1998) . Therefore, the MEK-ERK1/2-STC1 negative feedback loop downregulates the ERK1/2 prosurvival signaling pathway and decreases survival of MEFs in response to oxidative stress.
In further support of the conclusion that STC1 antagonizes MEK-ERK1/2 prosurvival function, pharmacological inhibition of ERK1/2 activation proved to be redundant in STC1 þ / þ MEFs but, in contrast, resulted in a phenotype rescue in STC1À/À MEFs, that is, sensitivity to oxidative stress was restored in STC1À/À MEFs to levels comparable to WT. This observation confirmed the existence of the feedback loop: if ERK1/2 were upstream of STC1 in a purely linear relationship, inhibitors of ERK1/2 would not be expected to have any effect in STC1À/À MEFs. Clearly, this was not the case: pharmacological inhibitors of ERK1/2 caused a marked decrease in survival of STC1À/À cells and, conversely, STC1 sensitized cells to oxidative stress by downregulating the activity of ERK1/2. Collectively, the results have revealed the existence of a novel negative feedback loop in which MEK-ERK1/2 prosurvival function is 'autoregulated' through STC1, the expres- Proposed model. STC1 acts in a negative feedback loop to regulate ERK1/2 signaling. Oxidative stress (for example, H 2 O 2 ), or stimulation of growth factor receptor signaling in which ERK1/2 acts as an intracellular mediator of proliferation, (for example, FGF) activates MEK and subsequently ERK1/2 for survival signaling. This is kept in check by STC1, the expression of which is dependent upon ERK1/2 activity. In the absence of STC1, the MEK and ERK1/2 activation is enhanced and this confers resistance to oxidative stress or augmented cell growth. FGF, fibroblast growth factor; MEFs, mouse embryo fibroblasts; STC1, Stanniocalcin-1.
A Nguyen et al sion of which is dependent upon ERK1/2 activity ( Figure 7) . The response of a cell to stress is complex, with the outcome being determined by the integrated signals from prosurvival and death pathways. Although the ultimate outcome of oxidative stress may be cell death, our observation that oxidative stress also activates the ERK1/2 prosurvival signaling pathway is in agreement with the results of others (Sundaresan et al., 1995; Wang et al., 1998) . ROS, the principal mediators of oxidative stress, can function in mitogenic signaling as secondary messengers (Sundaresan et al., 1995) , and are required for growth factor receptor tyrosine phosphorylation and subsequent proproliferative signaling (Finkel, 1998) . Our finding that STC1 modulates the ERK1/2 pathway indicates that the amplitude of the signal through this pathway can be controlled by STC1, thus regulating the sensitivity of a cell to stress.
Many independent studies have reported alterations in STC1 expression levels in response to different stresses (Iyer et al., 1999; Sheikh-Hamad et al., 2000; Chang et al., 2003) , but the significance of such changes in expression has hitherto been unknown. In light of our findings, it appears that STC1 functions in response to cellular stress to control the cell death vs survival decision, and this is consistent with two recent studies. In the first, recombinant STC1 protein resulted in an increase in the number of apoptotic chondrocytes in the growth plate of cultured rat metatarsals (Wu et al., 2006) , and in the other, STC1 expression was found to be regulated by p53, and was correlated with an increase in apoptosis of CNE-2 cells (Lai et al., 2007) . On the basis of our findings, it seems likely that STC1 exerts proapoptotic effects in response to cellular stress through its downregulation of MEK and consequent downregulation of ERK1/2 activity. ERK1/2 has previously been shown to be capable of inhibiting the apoptosis effector molecule caspase-3 (Adayev et al., 2003) , and also of upregulating the antiapoptotic Bcl-2 family members (Bai et al., 2002) . Inhibition of ERK1/2 activity by STC1 is, therefore, consistent with a proapoptotic effect.
Our data clearly show a role for STC1 in the oxidative stress response, in which STC1 functions to reduce survival. Intriguingly, Zhang et al. (2000) found that STC1 expression in the human adult neuronal tumor cell line, Paju, conferred resistance to hypoxia, and consequently proposed that STC1 acts as a 'molecular guard', protecting cells, rather than promoting cell death as we have found in our study. It is possible that the conflicting observations relating to STC1's impact upon cell survival arise from cell-type-specific effects: terminally differentiated cells, such as adult neurons, need to survive for the life-time of the organism and hence rarely undergo apoptosis (Benn and Woolf, 2004) . Another possible explanation of the discordant observations is the use of different stressors, which potentially activate different signaling pathways and cell responses.
The precise mechanism by which STC1 inhibits MEK activation and mediates apoptosis is not known and requires further investigation. It is possible that STC1 may mediate its effects through its putative role in calcium regulation. STC1 has been shown to be capable of regulating intracellular calcium (Sheikh-Hamad et al., 2000; Kanellis et al., 2003; Koizumi et al., 2007) , and the activation of pathways that govern cellular proliferation and death, such as the protein kinase C (PKC) pathway, rely heavily upon intracellular calcium signaling. The PKC pathway is of particular interest because it can promote MEK and ERK1/2 activation (Bai et al., 2002) and has also been shown to regulate STC1 expression (Yeung et al., 2003) . Classically, PKCs activate MEK through a signaling cascade involving Raf-1, but in our study, we did not find differences in Raf-1 activation between STC1 þ / þ and STC1À/À MEFs, so if PKC is involved, it appears to be independent of Raf-1 function. PKC is also known to interact with protein phosphatase 2A (Lee et al., 2008) , and it is possible that STC1 cooperates with this enzyme to inhibit the phosphorylation and activation of MEK.
Our observations relating to STC1s proapoptotic function provide an explanation for the reported association between elevated STC1 expression in cancer and favorable patient outcomes. In a study following 72 cases of primary breast cancer and their metastatic relapses, levels of STC1 expression were correlated with tumor dormancy, with higher levels being detected in cases with very late relapses (Joensuu et al., 2008) . In that study, and in a study by Bouras et al. (2002) , high levels of STC1 expression were found to be associated with estrogen receptor positivity, which is a marker of good prognosis. Furthermore, the tumor suppressors BRCA1 and p53 have both been reported to upregulate STC1 gene expression (Welcsh et al., 2002; Lai et al., 2007) . Continued expression of these genes in cancers is usually associated with good prognosis, and this may be explained in part by STC1 acting as a downstream mediator of apoptosis.
Stanniocalcin-1 was originally identified in a cDNA library screen as a gene differentially expressed between pre-crisis and post-crisis human fibroblasts (Chang et al., 1995) : in these cells, downregulation of STC1 expression accompanied immortalization, a key step in the carcinogenesis process. Our observation here that STC1À/À cells are resistant to oxidative stress-induced cell death further suggests that the downregulation of STC1 expression during carcinogenesis may favor the accumulation of cells with oxidative DNA lesions, which can drive further neoplastic progression.
The finding that STC1 is involved in the cellular response to stress may provide an explanation for the observation that mice, which are null for this highly conserved gene, have no obvious phenotype when housed under standard laboratory conditions. The in vitro data suggest that a phenotype may become apparent in vivo if the mice are subjected to the appropriate environmental stressors.
Materials and methods

Cell culture
MEFs were isolated from E13.5 to E14.5 STC1 þ / þ and STC1À/À littermate embryos using standard procedures (Xu, (Todaro and Green, 1963) .
For H 2 O 2 treatment, cells were washed twice with phosphate-buffered saline (PBS), exposed for 45 min to 40 mm H 2 O 2 (BDH Chemicals, Dorset, UK) in serum-free medium, and then the medium was replaced with fresh complete growth medium. Cells were harvested 24 h post-treatment for DNA content analysis or apoptosis measurement, or 72 h posttreatment for counting using a Coulter Particle Counter (Beckman-Coulter, Fullerton, CA, USA). To inhibit MEK, cells were exposed to 50 mm PD98059 (Calbiochem, Gibbstown, NJ, USA) for 2 h before H 2 O 2 treatment, or cultured in 10 mm UO126 (Promega, Madison, WI, USA) following H 2 O 2 treatment. Recombinant human bFGF (Sigma-Aldrich) was reconstituted in 20 mM Tris pH 7.0 and diluted in Dulbecco's Modified Eagle Medium/10% fetal bovine serum. Cells were washed twice with PBS, exposed to 80 ng/ml bFGF for 48 h, and then harvested and counted.
Generation of stable STC1-expressing cell lines
Immortalized STC1À/À MEFs were transfected with cytomegalovirus-huSTC1-iRES-NEO or cytomegalovirus-iRES-NEO using Fugene 6 Transfection Reagent (Roche, Basel, Switzerland), passaged 24 h later, and exposed to 300 mg/ml G418 (Roche) after a further 24 h. G418-resistant clones were picked and cultured individually.
Growth curve
MEFs were plated in triplicate at initial seeding densities of 4 Â 10 4 per 9.6 cm 2 well, or 1 Â 10 4 per 9.6 cm 2 well of a 6-well plate for low cell density growth conditions, and harvested for counting after 2, 4 and 6 days in culture. Cumulative PDs were determined by log 2 (number of cells harvested/number of cells plated).
Colony formation assays A total of 4 Â 10 2 or 6 Â 10 2 MEFs were plated in 100 mm dishes (Becton Dickinson, Franklin Lakes, NJ, USA) on a layer of 1 Â 10 5 MEFs of the same genotype mitotically inactivated with 90 Gy-g irradiation. The cultures were grown in an atmosphere of 5% CO 2 and either 20% O 2 or 3% O 2 at 37 1C for 2 weeks before they were fixed and stained with 0.2% crystal violet/2.5% acetic acid.
RNA extraction and real-time RT-PCR RNA was isolated from cells using TRIzol (Invitrogen, Madison, WI, USA) and reverse transcribed at 37 1C for 2 h with 200 U Moloney murine leukemia virus reverse transcriptase (Promega). Real-time RT-PCR analyses were performed in triplicate using SYBR Green PCR Master Mix (Applied Biosystems, Carlsbad, CA, USA): 2 min incubation at 50 1C, pre-denaturation at 95 1C for 10 min, followed by 40 cycles of 95 1C, 15 s; and 60 1C, 1 min. The 18S rRNA was quantified as control. The STC1 primers were 5 0 -AAGTCATACAGCAGCC CAATCA-3 0 and 5 0 -CCAGAAGGCTTCGGACAAGTC-3 0 .
Intracellular ROS measurement
Cells were harvested, washed once with PBS and resuspended in 50 mM carboxy-H 2 DCFDA (molecular probes, Invitrogen). After 30 min incubation at 37 1C in the dark, cells were resuspended in PBS. DCF fluorescence was measured at 495 nm/530 nm using a VICTOR fluorescence plate reader (Perkin Elmer, Boston, MA, USA).
Western blotting
Cells were lysed in radio immunoprecipitation assay buffer (1% NP-40, 0.5% sodium deoxycholic acid, 0.1% SDS, 120 mM NaCl, 50 mM Tris-HCl, pH 8.0) supplemented with protease inhibitor tablets (Roche), flash frozen on dry ice, thawed and centrifuged at 16 000 Â g at 4 1C to remove debris. Protein concentration was determined by the BCA protein assay (Pierce). Proteins were separated by SDS-polyacrylamide gel electrophoresis in 10% polyacrylamide gels and transferred to immobilon-P polyvinylidene fluoride membranes (Millipore, Billerica, MA, USA). Membranes were stained with Ponceau-S (0.2% Ponceau S, 3% trichloroacetic acid, 3% sulfosalicylic acid) to verify even loading, then blocked with 5% bovine serum albumin (BSA)/0.1% Tween 20/Tris-buffered saline (100 mM Tris, pH 7.5, 150 mM NaCl) and incubated with rabbit polyclonal antiphospho ERK1/2 (Thr-202/Tyr-204), rabbit polyclonal antiphospho MEK (Ser-217/221), or rabbit monoclonal anti-phospho Raf-1 (Ser338) (all from Cell Signaling Technology, Boston, MA, USA), followed by polyclonal swine antirabbit immunoglobuline-G conjugated to horseradish peroxidase (Dako, Glostrup, Denmark). Peroxidase activity was detected using Super Signal West Pico Chemi-luminescent substrate (Pierce).
DNA content analysis
Floating and adherent cells from each cell culture were washed once in PBS, fixed in ice cold 70% ethanol for 30 min, resuspended in PBS and treated with 0.5 mg RNase (SigmaAldrich) and 25 mg propidium iodide (Sigma-Aldrich), in 250 ml total volume. Stained samples were incubated at 37 1C for 30 min, and then left at room temperature in the dark for 10 min before FACS analysis (FACSCanto, BD Biosciences, San Jose, CA, USA).
Caspase assay
For the Caspase Glo 3/7 assay (Promega), luminescence was measured with a TopCount NXT Microplate Scintillation and Luminescence Counter (Packard).
